Role of IL-6, IL-2, and IL-4 in the in vitro induction of cytotoxic T cells - PubMed (original) (raw)
. 1992 Nov 15;149(10):3316-20.
Affiliations
- PMID: 1431108
Role of IL-6, IL-2, and IL-4 in the in vitro induction of cytotoxic T cells
H Quentmeier et al. J Immunol. 1992.
Abstract
The mode of IL-6-induced differentiation of Con A-stimulated CD4-CD8+ CTL-P was examined. Through application of neutralizing anti-IL-6, anti-IL-2, and anti-IL-4 mAb it was shown that IL-6 is an "early acting" factor for development of accessory cell-depleted thymocytes. IL-2 and IL-4 are obligatory "late acting" factors for this process. In accordance IL-4, but not IL-6, induced active CTL from CD4-CD8+ CTL-P. The increase of CD4-CD8+ CTL originates at least partially from CD4+CD8+ cells differentiating to active CTL in vitro. CTL development was paralleled by an increase in CD4-CD8+ cells and by a distinct increase in [3H]TdR uptake on day 2 of cultivation. Our data suggest that IL-6 induces Th cells to produce IL-2 and IL-4, the mediators for final differentiation of CD4-CD8+ cells.
Similar articles
- Production of interleukin 2 and interleukin 4 by immune CD4-CD8+ and their role in the generation of antigen-specific cytotoxic T cells.
Horvat B, Loukides JA, Anandan L, Brewer E, Flood PM. Horvat B, et al. Eur J Immunol. 1991 Aug;21(8):1863-71. doi: 10.1002/eji.1830210813. Eur J Immunol. 1991. PMID: 1907920 - IL-10: a novel cytotoxic T cell differentiation factor.
Chen WF, Zlotnik A. Chen WF, et al. J Immunol. 1991 Jul 15;147(2):528-34. J Immunol. 1991. PMID: 1906502 - Th1 development of naive CD4+ T cells is inhibited by co-activation with anti-CD4 monoclonal antibodies.
Goedert S, Germann T, Hoehn P, Koelsch S, Palm N, Rüde E, Schmitt E. Goedert S, et al. J Immunol. 1996 Jul 15;157(2):566-73. J Immunol. 1996. PMID: 8752903 - IL6 and the T-cell response.
Houssiau F, Van Snick J. Houssiau F, et al. Res Immunol. 1992 Sep;143(7):740-3. doi: 10.1016/0923-2494(92)80014-c. Res Immunol. 1992. PMID: 1439147 Review. No abstract available.
Cited by
- Actin depolymerizing factor-based nanomaterials: A novel strategy to enhance _E. mitis_-specific immunity.
Yu Z, Xu L, He K, Lu M, Yan R, Song X, Li X. Yu Z, et al. Front Immunol. 2022 Dec 21;13:1080630. doi: 10.3389/fimmu.2022.1080630. eCollection 2022. Front Immunol. 2022. PMID: 36618362 Free PMC article. - PLGA Nanospheres as Delivery Platforms for Eimeria mitis 1a Protein: A Novel Strategy to Improve Specific Immunity.
Xu L, Yu Z, He K, Wen Z, Aleem MT, Yan R, Song X, Lu M, Li X. Xu L, et al. Front Immunol. 2022 May 26;13:901758. doi: 10.3389/fimmu.2022.901758. eCollection 2022. Front Immunol. 2022. PMID: 35693811 Free PMC article. - Growth stimulation of tumor-specific cytotoxic T lymphocytes on concanavalin a-immobilized carrier beads.
Liu SQ, Liu LS, Ohno T. Liu SQ, et al. Cytotechnology. 1998 Jan;26(1):13-21. doi: 10.1023/A:1007924430570. Cytotechnology. 1998. PMID: 22359002 Free PMC article. - Activation-induced inhibition of interleukin 6-mediated T cell survival and signal transducer and activator of transcription 1 signaling.
Teague TK, Schaefer BC, Hildeman D, Bender J, Mitchell T, Kappler JW, Marrack P. Teague TK, et al. J Exp Med. 2000 Mar 20;191(6):915-26. doi: 10.1084/jem.191.6.915. J Exp Med. 2000. PMID: 10727454 Free PMC article. - Interleukin-6 and interleukin-12 participate in induction of a type 1 protective T-cell response during vaccination with a tuberculosis subunit vaccine.
Leal IS, Smedegârd B, Andersen P, Appelberg R. Leal IS, et al. Infect Immun. 1999 Nov;67(11):5747-54. doi: 10.1128/IAI.67.11.5747-5754.1999. Infect Immun. 1999. PMID: 10531224 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials